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Gregory L. Moneta, MD, Section EditorAtherosclerosis Across 4000 Years of Human History: The Horus
Study of Four Ancient Populations
Thompson RC, Allam AH, Lombardi GP, et al. Lancet 2013;381:1211-22.
Conclusion: Atherosclerosis was common in four preindustrial popu-
lations, including preagricultural hunter-gathers.
Summary: Human beings residing in very hot, cold, or dry environ-
ments have independently discovered how to mummify dead members of
their society. These, often preindustrial, cultures have created the opportu-
nity to study ancient human beings with modern computed tomography
scanning to assess the extent of vascular calciﬁcations in diffuse environ-
ments and cultures. Calcium is a nearly universal component of a mature
atherosclerotic plaque and is pathognomonic for atherosclerosis (Stary
HC et al, Circulation 1995;92:1355-74). The authors recently conﬁrmed
atherosclerotic calciﬁcations in 20 of 44 Egyptian mummies of individuals
who lived during several dynasties between 1981 BC and 364 CE (Common
Era) (Allam AH et al, J Am Coll Cardiol Imagining 2011;4:315-27). In this
current study the authors examined 137 mummies from populations of four
disparate geographic regions. Mummies were studied by whole-body
computed tomography scanning and included specimens from Ancient
Egypt, the Roman Era, Ancient Peru, and ﬁve cultures from Southwest
America (ca 1500 BCE to 1500 CE, ﬁve evacuation sites). Finally, there
were ﬁve ancient Unargan specimens from the Aleutian Islands of
modern-day Alaska. Mummies were selected for imaging on the basis of
a good state of preservation and the likelihood of being adult. Random
selection was not used. The population examined spanned >4000 years.
Atherosclerosis was regarded as deﬁnitive if calciﬁed plaque was seen on
the wall of an artery and considered probable if artery calciﬁcations were
seen along the expected course of an artery. Of the 137 mummies, 47
(34%) demonstrated probable or deﬁnitive atherosclerosis: 29 of 76 Ancient
Egyptians (38%), 13 of 51 Ancient Peruvians (25%), two of ﬁve ancestral
Puebloans (40%), and three of ﬁve Unangan hunter-gatherers (60%; P ¼
not signiﬁcant). Atherosclerosis was present in the aorta in 20% of
mummies, the iliac/femoral arteries in 18%, the popliteal/tibial arteries in
18%, carotid arteries in 12%. and the coronary arteries in only 4%. Of the
ﬁve vascular beds examined, atherosclerosis was present in one to two
beds in 25% of mummies, in three to four beds in 8%, and all ﬁve vascular
beds in only 1%. Age and time of death were positively correlated with
atherosclerosis: the mean age at death was 43 years (standard deviation
[SD], 10 years) for mummies with atherosclerosis vs 32 years (SD, 15 years)
for those without (P < .0001). Age also varied with the number of arterial
beds involved: the mean age was 32 years (SD, 15 years) for mummies with
no atherosclerosis, 42 years (SD, 10 years) for those with atherosclerosis in
one or two beds, and 44 years (8 years) for those with atherosclerosis in
three to ﬁve beds (P < .0001).
Comment: Atherosclerosis is assumed by many to be a modern
disease related to the modern lifestyle. These data, however, with ﬁndings
of atherosclerosis in premodern humans, raises the more-than-likely possi-
bility that atherosclerosis is reﬂective of a more basic predisposition to the
disease in humans. It may be that atherosclerosis should, to some degree,
be considered an inherent component to the human aging process and
not necessarily always speciﬁcally reﬂective of any speciﬁc diet or lifestyle.Intestinal Microbial Metabolism of Phosphatidylcholine and
Cardiovascular Risk
Tang WH, Wang Z, Levison BS, et al. N Engl Med 2013;368:1575-84.
Conclusions: The production of the proatherosclerotic metabolite
trimethylamine-N-oxide (TMAO) from dietary phosphatidylcholine is
dependent on metabolism by intestinal ﬂora. Increased TMAO is associated
with an increased incidence of major adverse cardiovascular events.
Summary: The authors recently described a potential role of the
phosphatidylcholine metabolic pathway involving gut ﬂora in contributing
to the pathogenesis of atherosclerotic coronary disease in an animal model
(Wang Z et al, Nature 2011;472:57-63). TMAO is an intestinal ﬂora-
dependent metabolite of the choline group of phosphatidylcholine that is
excreted in the urine (Simenhoff ML et al, Lancet 1976;2:818-21). Themajor dietary source of choline is lecithin, a part of the B-complex vitamin
family. Choline and its metabolites, such as betaine, can serve as a source of
the methyl groups required for proper metabolism of amino acids such as
homocysteine and methionine (Zeisel AQ et al, Annu Rev Nutr
2006;26:229-50). Diets rich in phosphatidylcholine (those containing
eggs, liver, beef, and pork) can contribute to the formation of the metabo-
lite trimethylamine, with conversion to TMAO. TMAO production may be
facilitated by intestinal microﬂora, thereby, potentially, providing a link
between atherogenic diets, intestinal microﬂora, and atherosclerotic disease.
The authors investigated the relationship of intestinal microﬂora-dependent
metabolism of dietary phosphatidylcholine, TMAO levels, and cardiovas-
cular events in humans. Plasma and urinary levels of TMAO and plasma
choline and betaine levels were measured with liquid chromatography and
gas spectrometry after a phosphatidylcholine challenge (two hard-boiled
eggs with deuterium [d9]-labeled phosphatidylcholine) in healthy partici-
pants before and after suppression of intestinal microbiota with oral
broad-spectrum antibiotics. Fasting plasma levels of TMAO were also exam-
ined in conjunction with incident major adverse cardiovascular events
(death, myocardial infarction, or stroke) during 3 years of follow-up in
4007 patients undergoing elective coronary angiography. The authors
found time-dependent increases in levels of TMAO and its [d9] isotopo-
logue, as well as other choline metabolites, after the phosphatidylcholine
challenge. TMAO plasma levels were suppressed after administration of
antibiotics and reappeared after withdrawal of antibiotics. Increased plasma
levels of TMAO were associated with an increased risk of major adverse
cardiovascular events (hazard ratio for highest vs lowest TMAO quartile,
2.54; 95% conﬁdence interval, 1.96-3.28; P < .001). After adjustment for
traditional cardiovascular risk factors, an elevated TMAO level predicted
an increased risk of major cardiovascular events (P < .001).
Comment: The authors have demonstrated that intestinal ﬂora partic-
ipate in phosphatidylcholine metabolism, resulting in circulating and urinary
TMAO. They also found increased high plasma levels of TMAO associated
with increased major adverse cardiovascular events as an independent risk
factor, even in low-risk patients. Because elevated TMAO levels are associ-
ated with diets rich in eggs and red meats, the authors have potentially
established a link between a so-called atherosclerotic diet, intestinal micro-
ﬂora, and adverse cardiovascular events. Modiﬁcation of intestinal micro-
ﬂora to decrease TMAO levels may someday be a therapeutic approach to
treatment or prevention of atherosclerosis.Comparison of Arteriovenous Fistulas and Arteriovenous Grafts in
Patients With Favorable Vascular Anatomy and Equivalent Access to
Health Care: Is a Reappraisal of the Fistula First Initiative Indicated?
Disbrow DE, Cull DL, Carsten CG 3rd, et al. J Am Coll Surg
2013;216:679-86.
Conclusion: For patients receiving hemodialysis via a dialysis access
catheter at the time of access placement, the maturation time, risk of non-
maturation, and interventions required to achieve a functional arterial
venous ﬁstula (AVF) can negate beneﬁts of an AVF over an arterial venous
graft (AVG).
Summary: For >10 years, the Fistula First Initiative has had
a profound inﬂuence on surgeons performing hemodialysis access, with
a sometimes evangelic dedication to the stated goal of increasing AVF
use. In 2014, the Centers for Medicare and Medicaid Services apparently
plan a pay-for-performance program that would cut reimbursements to dial-
ysis units not meeting set benchmarks for creating AVFs and for use of
AVFs. Data underlying the Fistula First Initiative have been based largely
on nonrandomized studies comparing outcomes of AVGs and AVFs.
Many argue there are clinical scenarios when an AVG makes sense over
an AVF if one considers maturation times, revisions required for maturation,
and ﬁstula failures. Indeed, “ﬁstula ﬁrst” was not likely intended to be
“ﬁstula only.” The authors of this article have questioned blind adherence
to the Fistula First Initiative. They contend patients receiving AVFs typically
have more favorable vascular anatomy and are referred earlier for access
placement than those who receive AVGs. This combination can result in
overestimation of the advantages of AVFs. In this study, the authors549
